Leaderboard

En | De
No articles selected!     View Cart  
You are here: Respiratory Tract » Neoplasms 02. December 2023
Search
medline.ch
Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Allergic Rhinitis - Hay Fever
Asthma
Bronchitis
COPD
Interstitial Lung Diseases
Pulmonary Embolism
Neoplasms
Pleural Diseases
Pneumonia
SARS
Sleep Apnoe Disorder
Tuberculosis
Cystic Fibrosis
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 6902  Previews Next
   
   Articles 1 - 20 / 138028  
   
Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study.
BMC Pulm Med
Kunimasa K, Matsumoto S, Honma K, Tamiya M, Inoue T, Kawamura T, Tanada S, Miyazaki A, Kanzaki R, Maniwa T, Okami J, Matsumoto Y, Goto K, Nishino K.
PMID: 38041137 [PubMed - in process]


Construction and validation of a nomogram to predict the overall survival of small cell lung cancer: a multicenter retrospective study in Shandong province, China.
BMC Cancer
Song Z, Ma H, Sun H, Li Q, Liu Y, Xie J, Feng Y, Shang Y, Ma K, Zhang N, Wang J.
PMID: 38041067 [PubMed - in process]


Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial.
Clin Lung Cancer
Hui C, Brown E, Wong S, Das M, Wakelee H, Neal J, Ramchandran K, Myall NJ, Pham D, Xing L, Yang Y, Kovalchuk N, Yuan Y, Lu Y, Xiang M, Chin A, Diehn M, Loo BW Jr, Vitzthum LK.
PMID: 38040540 [PubMed - as supplied by publisher]


Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: practical indications from an Italian multidisciplinary group.
Crit Rev Oncol Hematol
Malapelle U, Donne AD, Pagni F, Fraggetta F, Rocco EG, Pasello G, Perrone G, Pepe F, Vatrano S, Pignata S, Pinto C, Pruneri G, Russo A, Soto Parra HJ, Vallone S, Marchetti A, Troncone G, Novello S.
PMID: 38040072 [PubMed - as supplied by publisher]


Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial.
J Clin Oncol
Tan DSW, Felip E, de Castro G, Solomon BJ, Greystoke A, Cho BC, Cobo M, Kim TM, Ganguly S, Carcereny E, Paz-Ares L, Bennouna J, Garassino MC, Schenker M, Kim SW, Brase JC, Bury-Maynard D, Passos VQ, Deudon S, Dharan B, Song Y, Caparica R, Johnson BE.
PMID: 38039427 [PubMed - as supplied by publisher]


Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis.
Cancer Res Treat
Kim SH, Chung HS, Kim J, Kim MH, Lee MK, Kim I, Eom JS.
PMID: 38037321 [PubMed - as supplied by publisher]


Multi-classification model incorporating radiomics and clinic-radiological features for predicting invasiveness and differentiation of pulmonary adenocarcinoma nodules.
Biomed Eng Online
Sun H, Zhang C, Ouyang A, Dai Z, Song P, Yao J.
PMID: 38037082 [PubMed - in process]


Detection of NTRK fusions by RNA-based nCounter is a feasible diagnostic methodology in a real-world scenario for non-small cell lung cancer assessment.
Sci Rep
de Oliveira Cavagna R, de Andrade ES, Tadin Reis M, de Paula FE, Noriz Berardinelli G, Bonatelli M, Ramos Teixeira G, Garbe Zaniolo B, Mourão Dias J, da Silva FAF, Baston Silva CE, Xavier Reis M, Lopes Maia E, de Alencar TS, Jacinto AA, da Nóbrega Oliveira REN, Molina-Vila MA, Ferro Leal L, Reis RM.
PMID: 38036758 [PubMed - in process]


Benefits and risks of PD-1/PD-L1 inhibitors for recurrent small cell lung cancer: A systematic review and meta-analysis.
Crit Rev Oncol Hematol
Zhou J, Zhonghai DU, Liang Y, Zhang S.
PMID: 38036155 [PubMed - as supplied by publisher]


Molecular profiling of patients with advanced lung adenocarcinoma diagnosed between 2015 and 2020 in French Polynesia.
Respir Med Res
Messekher M, François H, Denis MG, Ferrer-Lopez P, Bost-Bezaud F, Mazières J, Parrat É.
PMID: 38035867 [PubMed - as supplied by publisher]


Circular RNA in Non-small Cell Lung Carcinoma: Identification of Targets and New Treatment Modalities.
Cancer Genomics Proteomics
Weidle UH, Birzele F.
PMID: 38035705 [PubMed - in process]


Bayesian survival extrapolation for cost-effectiveness analysis: a case study of RELAY for ramucirumab in combination with erlotinib in the treatment of non-small-cell lung cancer.
J Med Econ
Traore S, Sashegyi A, Winfree KB, Taipale KL, Jen MH.
PMID: 38035666 [PubMed - in process]


Development of clinical trials for non-small cell lung cancer drugs in China from 2005 to 2023.
Front Med (Lausanne)
Jia W, Yu H, Song L, Wang J, Niu S, Zang G, Liang M, Liu J, Na R.
PMID: 38034540 [PubMed]


Lipid-lowering drugs affect lung cancer risk via sphingolipid metabolism: a drug-target Mendelian randomization study.
Front Genet
Li H, Zhang L, Yang F, Feng X, Fu R, Zhao R, Li X, Li H.
PMID: 38034491 [PubMed]


Dietary and supplementary vitamin C intake and the risk of lung cancer: A meta‑analysis of cohort studies.
Oncol Lett
Tran DV, Luu XQ, Tran HTT, Myung SK.
PMID: 38034488 [PubMed]


Predictive Value of Skeletal Muscle Function Test Combined with Climbing Test for Postoperative Cardiopulmonary Complications in Patients with COPD and Concurrent Lung Cancer.
Int J Chron Obstruct Pulmon Dis
He Z, Li H, Cao B, Zan Z, Feng H, Wei Q, Liu K.
PMID: 38034469 [PubMed - in process]


Preoperative (18)F-FDG PET/CT and CT radiomics for identifying aggressive histopathological subtypes in early stage lung adenocarcinoma.
Comput Struct Biotechnol J
Choi W, Liu CJ, Alam SR, Oh JH, Vaghjiani R, Humm J, Weber W, Adusumilli PS, Deasy JO, Lu W.
PMID: 38034400 [PubMed]


Efficacy and safety of second-line therapy of docetaxel plus ramucirumab after first-line platinum-based chemotherapy plus immune checkpoint inhibitors in non-small cell lung cancer (SCORPION): a multicenter, open-label, single-arm, phase 2 trial.
EClinicalMedicine
Matsuzawa R, Morise M, Ito K, Hataji O, Takahashi K, Koyama J, Kuwatsuka Y, Goto Y, Imaizumi K, Itani H, Yamaguchi T, Zenke Y, Oki M, Ishii M.
PMID: 38034077 [PubMed]


Evaluation of the effectiveness of a nationwide precision medicine program for patients with advanced non-small cell lung cancer in Germany: a historical cohort analysis.
Lancet Reg Health Eur
Kästner A, Kron A, van den Berg N, Moon K, Scheffler M, Schillinger G, Pelusi N, Hartmann N, Rieke DT, Stephan-Falkenau S, Schuler M, Wermke M, Weichert W, Klauschen F, Haller F, Hummel HD, Sebastian M, Gattenlöhner S, Bokemeyer C, Esposito I, Jakobs F, von Kalle C, Büttner R, Wolf J, Hoffmann W.
PMID: 38034041 [PubMed]


The predictive value of modified-DeepSurv in overall survivals of patients with lung cancer.
iScience
Lei J, Xu X, Xu J, Liu J, Wang Y, Wu C, Zhang R, Zhang Z, Jiang T.
PMID: 38033628 [PubMed]


   
   Articles 1 - 20 / 138028    Page 1 of 6902  Previews Next

 
Rect Bottom
Adserver Footer
 

Username

Password

 

 

Forgot your username or password?

 

New User? Sign Up

Register to My Medline!

 

Learn more about the My Medline experience

more >>

  Time frame  
   

Sky right 1